<DOC>
	<DOCNO>NCT02760979</DOCNO>
	<brief_summary>This study evaluate effect Denosumab decrease periprosthetic bone resorption Total Knee Arthroplasty compare placebo 60 patient ( 30 placebo 30 Denosumab ) within year surgery .</brief_summary>
	<brief_title>The Efficacy Denosumab Decreasing Periprosthetic Bone Loss Patients With Total Knee Arthroplasty</brief_title>
	<detailed_description>Periprosthetic bone resorption Total Knee Arthroplasty occur consequence prosthetic implant bone . Some patient ( 13 % ) develop aseptic failure prosthesis need revision surgery . 2 group patient treat Placebo Denosumab double blind prospective trial . Densitometry , Knee society score ( KSS ) , Western Ontario McMaster University Osteoarthritis Index ( WOMAC ) Medical Outcomes Study Short Form 36 ( SF-36 ) do group 0,3,6 12 month surgery .</detailed_description>
	<mesh_term>Bone Resorption</mesh_term>
	<mesh_term>Denosumab</mesh_term>
	<criteria>Patients Knee Osteoarthritis treat Total Knee Arthroplasty Patients allergy Denosumab Patients previous Osteoporosis treatment Patients renal failure Patients previous Bisphosphonate treatment 5 year</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>knee arthroplasty</keyword>
</DOC>